SciClone Pharmaceuticals’ Hong Kong Initial Public Offering And Listing

Sonia Carcano
Tagged:

Clifford Chance, Maples and Calder JunHe advised SciClone Pharmaceuticals on its US$281 million initial public offering and listing on the main board of the Hong Kong…

This content is for Standard 1 Year members only.
Login Join Now
Sonia Carcano

Author: Sonia Carcano

…

This content is for Standard 1 Year members only.
Login Join Now